Bilateral sensorineural hearing loss as a first symptom of chronic myelogenous leukemia.
Genden
E M
EM
Department of Otolaryngology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Bahadori
R S
RS
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001299:Audiometry; D005260:Female; D005500:Follow-Up Studies; D006312:Hearing Loss, Bilateral / Q000209:etiology*; D006319:Hearing Loss, Sensorineural / Q000209:etiology*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged
D000970:Antineoplastic Agents; D006918:Hydroxyurea